No impact on long-term survival of prolonged ICU stay and re-admission for patients undergoing cytoreductive surgery with HIPEC

Abstract Background Cytoreductive surgery (CRS) and Hyperthermic intraperitoneal chemotherapy (HIPEC) are promising new approaches of peritoneal metastases. However these surgical procedures are associated with a high morbidity rate thus intensive care (IC) management following serious complications...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of surgical oncology 2016-06, Vol.42 (6), p.855-860
Hauptverfasser:	Wallet, F., Dr, Maucort Boulch, D., Dr, Malfroy, S., Dr, Ledochowski, S., Dr, Bernet, C., Dr, Kepenekian, V., Dr, Passot, G., Dr, Vassal, O., Dr, Piriou, V., Pr, Glehen, O., Pr, Friggeri, A., Dr
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bacteriology Chemotherapy, Adjuvant Chemotherapy, Cancer, Regional Perfusion Combined Modality Therapy Cytoreduction Surgical Procedures Cytoreductive surgery Follow-Up Studies Hematology, Oncology and Palliative Medicine HIPEC Humans Hyperthermia, Induced Immunology Intensive care unit Intensive Care Units Life Sciences Long term outcome Microbiology and Parasitology Neoplasm Staging Peritoneal Neoplasms Prognosis Surgery Survival Rate Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!